NRD
IDXX icon

Nebula Research & Development’s Idexx Laboratories IDXX Stock Holding History

Nebula Research & Development’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,891
Closed -$782K – 1035
2024
Q4 		$782K Buy
+1,891
New +$829K 0.09% 380
2024
Q3 		– Sell
-1,592
Closed -$776K – 1050
2024
Q2 		$776K Buy
1,592
+1,141
+253% +$573K 0.13% 289
2024
Q1 		$244K Sell
451
-2,363
-84% -$1.29M 0.05% 601
2023
Q4 		$1.56M Buy
+2,814
New +$1.32M 0.47% 19

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Nebula Research & Development's IDXX Position: Q1 2025 in Review

Nebula Research & Development sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 1,891 shares — an estimated $782K sold.

Nebula Research & Development first reported a position in IDXX in Q4 2023 and held it in 4 quarters. The position peaked at $1.56M in Q4 2023. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Nebula Research & Development reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Nebula Research & Development sold 1,891 Idexx Laboratories shares in Q1 2025, an estimated $782K.
  • Nebula Research & Development first reported a position in Idexx Laboratories in Q4 2023 and held it in 4 quarters.
  • Nebula Research & Development's Idexx Laboratories position peaked at $1.56M in Q4 2023.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Nebula Research & Development's 13F filing for Q1 2025, filed 15 May 2025.